Thank you for helping us by filling out these questionnaires. We would like to make sure you are clear that

• Its purpose is to inform aspects of our submission to NICE (the National Institute of Clinical Excellence) which is currently assessing its guidance on Topotecan, pegylated liposomal doxorubicin hydrochloride (Caelyx) and Paclitaxel (Taxol), as treatments for recurring or resistant ovarian cancer.
• It is not for medical research purposes, but is a snapshot of patient experience.
• No medical details will be retained on our computers. You are not asked for your name or other identifying features. If you are submitting this form by email we shall not retain your details unless you agree.

To Fill out the Caelyx Questionnaire click here

To Fill out the Taxol Questionnaire click here

To Fill out the Topotecan Questionnaire click here

The questionnaire is an adaption based on the Chemotherapy Symptom Assessment Scale (C-SAS) (Brown et al (2001)) International Journal of Nursing Studies 38 497-510 and the EORTC QLQ-C30, by the following health professionals:

• Hani Gabra, Professor of Medical Oncology, Imperial College, London
• Cathy Hughes, Senior Research Nurse, West London Cancer Research Network
• Glyn Jarvis, Psychologist and Programme Director, Maggie Keswick Jencks Cancer Caring Centre, Edinburgh

About HHMT

As you have found this questionnaire via our website, we hope you have already found out about some of the work that we do, in particular the fact that we are raising funds for a UK ovarian cancer research unit. We rely on voluntary donations for funding, so any support you can give us in addition to your time now, is greatly valued. If you would a fundraising pack, or leaflets to give out to people to help raise awareness of the disease, please email us at info@hhmt.org